×
About 9,125 results

ALLMedicine™ Cutaneous Melanoma Center

Research & Reviews  4,459 results

Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort...
https://doi.org/10.1245/s10434-020-09224-9
Annals of Surgical Oncology; Bogach J, Wright FC et. al.

Oct 17th, 2020 - Melanoma and the immune system are intimately related. However, the association of immunosuppressive medications (ISMs) with survival in melanoma is not well understood. The study evaluated this at a population level. A cohort of patients with a d...

Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma p...
https://doi.org/10.1111/pcmr.12937
Pigment Cell & Melanoma Research; Fazio M, van Rooijen E et. al.

Oct 16th, 2020 - A progressive increase in copy number variation (CNV) characterizes the natural history of cutaneous melanoma progression towards later disease stages, but our understanding of genetic drivers underlying chromosomal arm-level CNVs remains limited....

Thyroid Metastasis From Cutaneous Melanoma on an 18F-FDG PET/CT Study.
https://doi.org/10.1097/RLU.0000000000003337
Clinical Nuclear Medicine; León-Asuero-Moreno I, García-Gómez FJ et. al.

Oct 16th, 2020 - The thyroid gland is an uncommon location for metastasis. We report a 59-year-old woman with a history of cutaneous malignant melanoma. A unique hypermetabolic mass on the left thyroid lobe was identified by control F-FDG PET/CT scan, leading to d...

Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentigino...
https://doi.org/10.5858/arpa.2020-0330-OA
Archives of Pathology & Laboratory Medicine; Cho WC, Wang WL et. al.

Oct 14th, 2020 - Molecularly distinct from cutaneous melanomas arising from sun-exposed sites, acral lentiginous melanomas (ALMs) typically lack ultraviolet-signature mutations, such as telomerase reverse transcriptase (TERT) promoter mutations. Instead, ALMs show...

Cutaneous Melanoma Arising in Congenital Melanocytic Nevus: A Retrospective Observation...
https://doi.org/10.1159/000510221
Dermatology (Basel, Switzerland); Caccavale S, Calabrese G et. al.

Oct 14th, 2020 - Congenital melanocytic nevi (CMN) are benign proliferations of melanocytes usually present at birth. The magnitude of the melanoma risk for CMN is controversial, generating an ongoing debate on the best approach to manage these lesions. To perform...

see more →

Guidelines  29 results

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2019.0018
Journal of the National Comprehensive Cancer Network : JNCCN; Coit DG, Thompson JA et. al.

Apr 8th, 2019 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. Thi...

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/4/article-p367.xml

Mar 31st, 2019 - For adjuvant treatment of melanoma in patients rendered free of disease by surgery, traditional systemic therapy approaches have proven to be ineffective. Adjuvant interferon alfa (IFN alfa), particularly high-dose IFN alfa, has been widely used i...

Guidelines of care for the management of primary cutaneous melanoma.
https://doi.org/10.1016/j.jaad.2018.08.055
Journal of the American Academy of Dermatology; Swetter SM, Tsao H et. al.

Nov 5th, 2018 - The incidence of primary cutaneous melanoma continues to increase each year. Melanoma accounts for the majority of skin cancer-related deaths, but treatment is usually curative following early detection of disease. In this American Academy of Derm...

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immun...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977556
Journal for Immunotherapy of Cancer; Sullivan RJ, Atkins MB et. al.

May 31st, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien...

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunother...
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0362-6
Sullivan, R.

May 29th, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patien.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4,545 results

Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort...
https://doi.org/10.1245/s10434-020-09224-9
Annals of Surgical Oncology; Bogach J, Wright FC et. al.

Oct 17th, 2020 - Melanoma and the immune system are intimately related. However, the association of immunosuppressive medications (ISMs) with survival in melanoma is not well understood. The study evaluated this at a population level. A cohort of patients with a d...

Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma p...
https://doi.org/10.1111/pcmr.12937
Pigment Cell & Melanoma Research; Fazio M, van Rooijen E et. al.

Oct 16th, 2020 - A progressive increase in copy number variation (CNV) characterizes the natural history of cutaneous melanoma progression towards later disease stages, but our understanding of genetic drivers underlying chromosomal arm-level CNVs remains limited....

Thyroid Metastasis From Cutaneous Melanoma on an 18F-FDG PET/CT Study.
https://doi.org/10.1097/RLU.0000000000003337
Clinical Nuclear Medicine; León-Asuero-Moreno I, García-Gómez FJ et. al.

Oct 16th, 2020 - The thyroid gland is an uncommon location for metastasis. We report a 59-year-old woman with a history of cutaneous malignant melanoma. A unique hypermetabolic mass on the left thyroid lobe was identified by control F-FDG PET/CT scan, leading to d...

Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentigino...
https://doi.org/10.5858/arpa.2020-0330-OA
Archives of Pathology & Laboratory Medicine; Cho WC, Wang WL et. al.

Oct 14th, 2020 - Molecularly distinct from cutaneous melanomas arising from sun-exposed sites, acral lentiginous melanomas (ALMs) typically lack ultraviolet-signature mutations, such as telomerase reverse transcriptase (TERT) promoter mutations. Instead, ALMs show...

Cutaneous Melanoma Arising in Congenital Melanocytic Nevus: A Retrospective Observation...
https://doi.org/10.1159/000510221
Dermatology (Basel, Switzerland); Caccavale S, Calabrese G et. al.

Oct 14th, 2020 - Congenital melanocytic nevi (CMN) are benign proliferations of melanocytes usually present at birth. The magnitude of the melanoma risk for CMN is controversial, generating an ongoing debate on the best approach to manage these lesions. To perform...

see more →

News  91 results

Lifetime indoor tanning raises risk of cutaneous squamous cell carcinoma
https://www.mdedge.com/hematology-oncology/article/209487/nonmelanoma-skin-cancer/lifetime-indoor-tanning-raises-risk?channel=39313
Heidi Splete

Oct 5th, 2019 - Women who accumulated more indoor tanning sessions over time significantly increased their risk for squamous cell cancer over women who never engaged in indoor tanning, based on data from 159,419 women. Previous research has examined associations.

Rapidly growing lesions on the forehead
https://www.mdedge.com/familymedicine/article/202581/oncology/rapidly-growing-lesions-forehead/page/0/2?channel=203
MDedge Family Medicine;

Jun 10th, 2019 - This case required a multidisciplinary team The patient underwent magnetic resonance imaging and positron emission tomography/computed tomography; the scans revealed no metastatic disease. She was evaluated by a multidisciplinary head and neck can.

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/4/article-p367.xml

Mar 31st, 2019 - For adjuvant treatment of melanoma in patients rendered free of disease by surgery, traditional systemic therapy approaches have proven to be ineffective. Adjuvant interferon alfa (IFN alfa), particularly high-dose IFN alfa, has been widely used i...

AAD 2019 meeting wrap-up
https://www.mdedge.com/internalmedicine/article/195921/aad-2019-meeting-wrap?channel=116

Mar 9th, 2019 - The 2019 annual meeting of the American Academy of Dermatology just wrapped up. Today's bonus episode focuses on highlights from the meeting.

31-GEP test predicts likelihood of metastasis for cutaneous melanoma
https://www.mdedge.com/hematology-oncology/article/195674/melanoma/31-gep-test-predicts-likelihood-metastasis-cutaneous?channel=39313
Jeff Craven

Mar 5th, 2019 - WASHINGTON – The 31-gene expression profile test has met the highest level of evidence under the Strength of Recommendation Taxonomy (SORT) method as a prognostic marker for accurately predicting recurrence-free survival and distant metastasis-fre.

see more →